Quoin Pharmaceuticals, Ltd. of ASHBURN, VA, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-23. The offering totals $105.3M, of which $105.3M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 29 people.
| Name | Role | Location |
|---|---|---|
| Denise Bridget Carter | Director | Ashburn, VA |
| Joseph Bridget Cooper | Director | Ashburn, VA |
| James Bridget Culverwell | Director | Ashburn, VA |
| Dennis Bridget Langer | Director | Ashburn, VA |
| Natalie Bridget Leong | Director | Ashburn, VA |
| Michael Myers | Director | Ashburn, VA |
| Michael Bridget Sember | Director | Ashburn, VA |
| Denise Bridget Carter | Executive Officer | Ashburn, VA |
| Sally Bridget Lawlor | Executive Officer | Ashburn, VA |
| Michael Myers | Executive Officer | Ashburn, VA |
| Dennis Langer | Director | Naples, FL |
| James Culverwell | Director | Holytown, Motherwell, X0 |
| Gordon Dunn | Executive Officer | Tel Aviv, L3 |
| Michael Sember | Director | Tel Aviv, L3 |
| Denise Carter | Director | Tel Aviv, L3 |
| Denise Carter | Executive Officer | Tel Aviv, L3 |
| Natalie Leong | Director | Tel Aviv, L3 |
| Joseph Cooper | Director | Tel Aviv, L3 |
| Yuval Nuriel Berman | Director | Kfar Saba, L3 |
| Eyal Nuriel Leibovitz | Executive Officer | Kfar Saba, L3 |
| David Nuriel Braun | Director | Kfar Saba, L3 |
| Michael Nuriel Berelowitz | Director | Kfar Saba, L3 |
| Abraham Nuriel Nahmias | Director | Kfar Saba, L3 |
| Shai Nuriel Yarkoni | Director | Kfar Saba, L3 |
| Shai Nuriel Yarkoni | Executive Officer | Kfar Saba, L3 |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2022-08-31 | D | $194K | $194K |
| 2018-02-09 | D | $4.0M | $4.0M |
| 2017-09-19 | D | $4.3M | $4.3M |